论文部分内容阅读
目的观察畅脉胶囊的临床疗效。方法将172例高血压病患者、84例冠心病心绞痛患者、109例高脂血症患者均随机分成两组。治疗组在常规西药治疗基础上加服畅脉胶囊4粒,每日3次。对照组分别予常规降压西药治疗、加服地奥心血康及给予脂必妥治疗。结果治疗组分别在控制血压、改善冠心病心绞痛、降脂方面,疗效均优于对照组,两组比较具有显著性差异(P<0.05)。结论畅脉胶囊具有较好的活血化瘀、祛痰通络、平肝熄风的功效。
Objective To observe the clinical curative effect of Changmai capsules. Methods 172 patients with hypertension, 84 patients with coronary heart disease and 109 patients with hyperlipidemia were randomly divided into two groups. The treatment group was given 4 capsules of Changmai Capsule on the basis of conventional Western medicine treatment, 3 times a day. The control group was treated with conventional antihypertensive western medicine, plus Dioxinxuekang, and given Zhibituo. Results The curative effect of the treatment group was better than that of the control group in controlling blood pressure, improving coronary heart disease and angina pectoris, and lowering lipids. There was a significant difference between the two groups (P<0.05). Conclusion Changmai capsules have good efficacy in promoting blood circulation, removing blood stasis, clearing liver and extinguishing liver.